Skip to content

MULTIGEN 2 8400-000-000Recalls & reported problems

Stryker Corporation · RF GENERATOR · Class 2

Adverse event reports
9
Deaths reported
0
Injuries reported
4
Recalls naming it
0

Summary

The FDA's MAUDE database contains 9 adverse event reports that list this exact device (DI 07613327173642), received between Jul 6, 2021 and Jul 24, 2025 — classified as 4 injuries, 5 malfunctions.

The most frequently reported specific device problem is “Energy Output Problem” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 1 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 1 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 1 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem4
  • Energy Output Problem3
  • Insufficient Device Problem Information2
  • Defibrillation/Stimulation Problem1
  • Excessive Heating1
  • Overheating of Device1

Patient problems

  • Pain7
  • Inadequate Pain Relief4
  • Electric Shock3
  • No Clinical Signs, Symptoms or Conditions2
  • Ambulation or Postural Difficulties1
  • Arrhythmia1
  • Chest Pain1
  • Fall1

Recent adverse event reports

The 9 most recent of 9 reports, in the reporter's own words as published by the FDA.

  • MalfunctionJul 24, 2025Energy Output Problem; Energy Output Problem

    IT WAS REPORTED THAT THE PATIENT WAS SHOCKED DURING A PROCEDURE WITH A RF GENERATOR. THE PATIENT STATED HE HAS EXPERIENCED TACHYCARDIA, CHEST PAIN, AND FATIGUE. THE PATIENT ALSO STATED HE HAS EXPERIENCED FALLS, DIFFICULTY WALKING, EXTREME PAIN, NEUROLOGICAL ISSUES, AND A THIRD-DEGREE BURN. AT THIS TIME, IT IS UNKNOWN WHAT CAUSED THE SHOCK OR BURN TO THE PATIENT. ADDITIONAL INFORMATION IS BEING GATHERED.

    Patient problems: Ambulation or Postural Difficulties; Arrhythmia; Chest Pain; Fall; Fatigue; Full thickness (Third Degree) Burn; High Blood Pressure/ Hypertension; No Clinical Signs, Symptoms or Conditions; Pain; Unspecified Nervous System Problem

    MAUDE report 22586178 ↗
  • MalfunctionJan 7, 2025Defibrillation/Stimulation Problem; Defibrillation/Stimulation Problem

    IT WAS REPORTED THAT THE PATIENT HAS A DEFIBRILLATOR AND WAS SHOCKED TWICE BY THE RFA PROCEDURE BEING DONE IN THE CERVICAL SPINE. THE PROCEDURE WAS COMPLETED SUCCESSFULLY WITHOUT A CLINICALLY SIGNIFICANT DELAY AND NO MEDICAL INTERVENTION.

    Patient problems: Electric Shock

    MAUDE report 21098172 ↗
  • MalfunctionOct 23, 2024Overheating of Device; Excessive Heating; Overheating of Device; Excessive Heating

    IT WAS REPORTED THAT DURING USE IN A PROCEDURE AT THE USER FACILITY, A CAUTERY TIP BURNED HOLES IN DRAPES. IT WAS REPORTED THAT THERE WERE NO ADVERSE CONSEQUENCES AND NO MEDICAL INTERVENTION AS A RESULT OF THIS EVENT. IT WAS FURTHER REPORTED THAT THE PROCEDURE WAS COMPLETED SUCCESSFULLY, WITHOUT A SIGNIFICANT DELAY.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 20516130 ↗
  • MalfunctionAug 9, 2023Energy Output Problem; Insufficient Device Problem Information; Energy Output Problem; Insufficient Device Problem Information

    IT WAS REPORTED THAT DURING A RF PROCEDURE THE PATIENT, WHO HAD PACEMAKER, WAS SHOCKED. IT SHOULD BE NOTED THAT THE PROCEDURE WAS COMPLETED SUCCESSFULLY AND THERE WAS NO MEDICAL INTERVENTION OR SURGICAL DELAYS.

    Patient problems: Electric Shock; Pain

    MAUDE report 17487799 ↗
  • MalfunctionAug 9, 2023Energy Output Problem; Insufficient Device Problem Information; Energy Output Problem; Insufficient Device Problem Information

    IT WAS REPORTED THAT DURING A RF PROCEDURE THE PATIENT, WHO HAD PACEMAKER, WAS SHOCKED. IT SHOULD BE NOTED THAT THE PROCEDURE WAS COMPLETED SUCCESSFULLY AND THERE WAS NO MEDICAL INTERVENTION OR SURGICAL DELAYS.

    Patient problems: Electric Shock; Pain

    MAUDE report 17487797 ↗
  • InjuryJul 6, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT NOTED SEVERE PAIN AND A "SUNBURN FEELING" ON THE RIGHT LUMBAR SPINE DURING AND FOLLOWING AN L3-S1 PROCEDURE. LIDOCAINE AND MARCAINE WERE IN USE FOR LOCAL ANESTHETIC. THE CONSOLE WAS SET TO 80°C, AND NO MALFUNCTION WAS ALLEGED WITH THE EQUIPMENT. THE ABLATION PROCEDURE ITSELF WAS COMPLETED SUCCESSFULLY USING BACKUP EQUIPMENT. THE PATIENT RETURNED FOR FACET JOINT INJECTIONS CONSISTING OF LIDOCAINE, MARCAINE, AND DEXAMETHASONE TO TREAT DYSESTHESIA DUE TO WALLERIAN DEGENERATION THAT WAS ALLEGED TO HAVE OCCURRED DURING THE ORIGINAL ABLATION PROCEDURE.

    Patient problems: Inadequate Pain Relief; Pain

    MAUDE report 12124581 ↗
  • InjuryJul 6, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT NOTED SEVERE PAIN AND A "SUNBURN FEELING" ON THE LEFT LUMBAR SPINE FOLLOWING AN L1-L3 PROCEDURE. LIDOCAINE AND MARCAINE WERE IN USE FOR LOCAL ANESTHETIC AND PROPOFOL WAS USED FOR GENERAL ANESTHESIA. THE CONSOLE WAS SET TO 80°C, AND NO MALFUNCTION WAS ALLEGED WITH THE EQUIPMENT. THE ABLATION PROCEDURE ITSELF WAS COMPLETED BUT UNSUCCESSFUL FOR THE TREATMENT OF PAIN. THE PATIENT RETURNED FOR FACET JOINT INJECTIONS CONSISTING OF LIDOCAINE, MARCAINE, AND DEXAMETHASONE TO TREAT DYSESTHESIA DUE TO WALLERIAN DEGENERATION THAT WAS ALLEGED TO HAVE OCCURRED DURING THE ORIGINAL ABLATION PROCEDURE.

    Patient problems: Inadequate Pain Relief; Pain

    MAUDE report 12124555 ↗
  • InjuryJul 6, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT NOTED SEVERE PAIN AND A "SUNBURN FEELING" ON THE LEFT LUMBAR SPINE FOLLOWING AN L3-S1 PROCEDURE. LIDOCAINE AND MARCAINE WERE IN USE FOR LOCAL ANESTHETIC AND PROPOFOL WAS USED FOR GENERAL ANESTHESIA. THE CONSOLE WAS SET TO 80°C, AND NO MALFUNCTION WAS ALLEGED WITH THE EQUIPMENT. THE ABLATION PROCEDURE ITSELF WAS COMPLETED BUT UNSUCCESSFUL FOR THE TREATMENT OF PAIN. THE PATIENT RETURNED FOR FACET JOINT INJECTIONS CONSISTING OF LIDOCAINE, MARCAINE, AND DEXAMETHASONE TO TREAT DYSESTHESIA DUE TO WALLERIAN DEGENERATION THAT WAS ALLEGED TO HAVE OCCURRED DURING THE ORIGINAL ABLATION PROCEDURE.

    Patient problems: Inadequate Pain Relief; Pain

    MAUDE report 12124499 ↗
  • InjuryJul 6, 2021Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem

    IT WAS REPORTED THAT THE PATIENT NOTED SEVERE PAIN AND A "SUNBURN FEELING" ON THE LEFT CERVICAL SPINE FOLLOWING A L3-L6 PROCEDURE. LIDOCAINE AND MARCAINE WERE IN USE FOR LOCAL ANESTHETIC. THE CONSOLE WAS SET TO 60°C, AND NO MALFUNCTION WAS ALLEGED WITH THE EQUIPMENT. THE ABLATION PROCEDURE ITSELF WAS COMPLETED BUT UNSUCCESSFUL FOR THE TREATMENT OF PAIN. THE PATIENT RETURNED FOR FACET JOINT INJECTIONS CONSISTING OF LIDOCAINE, MARCAINE, AND DEXAMETHASONE TO TREAT DYSESTHESIA DUE TO WALLERIAN DEGENERATION THAT WAS ALLEGED TO HAVE OCCURRED DURING THE ORIGINAL ABLATION PROCEDURE.

    Patient problems: Inadequate Pain Relief; Pain

    MAUDE report 12124359 ↗

Other GENERATOR, LESION, RADIOFREQUENCY devices

All GENERATOR, LESION, RADIOFREQUENCY devices →

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.